Advanced search
Publication Cover
Expert Review of Quality of Life in Cancer Care Volume 2, 2017 - Issue 2
Journal homepage
106
Views
0
CrossRef citations to date
0
Altmetric
Review

Cancer patients at high risk for chemotherapy-induced nausea and vomiting – prediction assessments/tools

Rudolph M NavariMedicine, Division of Hematology Oncology, University of Alabama Birmingham School of Medicine, Birmingham, Alabama, 35294, USACorrespondence[email protected]
View further author information
Pages 103-108 | Received 05 Dec 2016, Accepted 08 Feb 2017, Published online: 01 Mar 2017

References

  • Bloechl-Daum B, Deuson RR, Mavros P, et al. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol. 2006;24:4472–4478.
  • Cohen L, de Moor CA, Eisenberg P, et al. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer. 2007;15:497–503.
  • Navari RM. Management of chemotherapy-induced nausea and vomiting: focus on new agents and new uses for older agents. Drugs. 2013;73:249–262.
  • Navari RM. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New Engl J Med. 2016;374:1356–1374.
  • Molassiotis A, Aapro M, Herrstedt J, et al. MASCC and ESMO antiemetic guidelines; introduction to the 2016 guideline update. Support Care Cancer. 2017;25:267–269.
  • Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetic American Society Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011;29:4189–4198.
  • Hesketh PJ, Bohike K, Lyman GH, et al. Antiemetics: American Society of Clinical Oncology focused guideline update. J Clin Oncol. 2015;34:381–386.
  • NCCN Clinical Practice Guidelines in Oncology version 2 2016. Antiemesis. National Comprehensive Cancer Network (NCCN) [online]. [cited 2015 Oct]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf.
  • Rha SY, Park Y, Song SK, et al. Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients. Support Care Cancer. 2016;24:3379–3389.
  • DiMattei VE, Carnelli L, Carrara L, et al. Chemotherapy-induced nausea and vomiting in women with gynecological cancer: a preliminary single-center study investigating medical and psychological risk factors. Cancer Nurs. 2016;39:E52–E59.
  • Takemoth H, Nishimura J, Komori T, et al. Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin chemotherapy in the SENRI trial: analysis of risk factors. Int J Clin Oncol. 2016. DOI:10.1007/s10147-016-1022-9.
  • Kiernan J. Genetic influence on chemotherapy-induced nausea and vomiting: a narrative review. Oncol Nurs Forum. 2016;43:389–393.
  • Warr D. Prognostic factors for chemotherapy-induced nausea and vomiting. Eur J Pharmacol. 2014;722:192–196.
  • Navari RM. The current status of the use of palonosetron. Expert Opinion Pharmacothera. 2013;14:1274–1281.
  • Curran MP, Robinson DM. Aprepitant: a review of its use in the prevention of nausea and vomiting. Drugs. 2009;69:1853–1858.
  • Aapro M, Carides A, Rapoport BL, et al. Aprepitant and fosaprepitant: a 10-year review of efficacy and safety. The Oncologist. 2015;20:450–458.
  • Navari RM. Profile of netupitant/palonosetron fixed dose combination (NEPA) and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV). Drug Des Devel Ther. 2015;9:155–161.
  • Navari RM. Rolapitant for the treatment of chemotherapy induced nausea and vomiting. Expert Rev Anticancer Therapy. 2015;15:1127–1133.
  • Navari RM, Einhorn LH, Loehrer PJ, et al. A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting. Support Care Cancer. 2007;15:1285–1291.
  • Tan L, Liu J, Liu X, et al. Clinical research of olanzapine for the prevention of chemotherapy-induced nausea and vomiting. J Exp Clin Cancer Res. 2009;28:1–7.
  • Navari RM, Gray SE, Kerr AC. Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. J Support Oncol. 2011;9:188–195.
  • Navari RM. Treatment of chemotherapy-induced nausea. Community Oncol. 2012;9:20–26.
  • Stern RM, Koch KL, Andrews PLR, editors. Nausea: mechanisms and management. New York: Oxford University Press; 2011.
  • Koga T, Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from vagal afferents and the area postrema in the pattern generator in the emetic act in dogs. Neurosci Res. 1992;14:366–379.
  • Yates BJ, Grelot L, Kerman IA, et al. Organization of the vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stem. Am J Physiol. 1994;267:R974–83.
  • Chan CW, Lam LW, Li CK, et al. Feasibility of psychoeducational interventions in managing chemotherapy-associated nausea and vomiting in pediatric oncology patients. Eur J Oncol Nurs. 2015;19:182–190.
  • Kamen C, Tejani MA, Chandwani K, et al. Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol. 2014;722:172–179.
  • Navari RM, Qin R, Ruddy KJ, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. New Engl J Med. 2016;375:134–142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.